Dr. Reddy’s Laboratories Limited reported Total Income for Q4 FY23 of ₹6,453.7 Crore up from ₹5,596.8 Crore year on year, a growth of 15.3%. Consolidated Net Profit of ₹960.1 Crore, surged from ₹97 Crore in the same quarter of the previous year. The Earnings per Share is ₹57.68, from ₹5.83 in the same quarter of the previous year.
Dr Reddy’s Laboratories Q4 FY23; Net Profit Surged Up To ₹960 Crore
Tags: pharmaceuticals
Related Post
- Syngene Q3 FY26 Earnings Results
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO)…
-
Grindwell Norton Q2 FY26 Earnings Results
Grindwell Norton Limited, engaged in manufacturing abrasives, ceramics & plastics and providing IT services, reported…
-
H.G. Infra Q2 FY26 Earnings Results
H.G. Infra Engineering Limited (HGIEL), an Indian road infrastructure company engaged in EPC services, maintenance…